Fairfax IDBI Bank acquisition could reshape financial services in India. Discover the implications of this strategic move.
Cancer drug price cuts are happening now, with reductions up to 70%. Find out how this impacts patients and the pharma industry.
Helus Pharma board pick raises questions about future direction and leadership.
FDA approval Teva marks a significant advancement in schizophrenia treatment with Weltruza.
Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Novo Nordisk weight loss drugs are seeing price cuts. Discover how this impacts accessibility and effectiveness for consumers.
